This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
In case of sale of your personal information, you may opt out by using the link. Do Not Sell My Personal Information

In January 2018, the international journal Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration published the results of a care management program for assistive devices in amyotrophic lateral sclerosis (ALS) via the Ambulanzpartner internet platform. The provision of assistive devices is of central importance in ALS. Despite its socio-medical relevance, the provision of assistive devices in ALS…

In 2017, the Ambulanzpartner Akademie is once again offering exciting seminars for participants in the care network and interested guests. The thematic focus this year is clearly on amyotrophic lateral sclerosis. Since Ambulanzpartner was founded in 2011, over 6,500 people with ALS have been cared for in our network. We would like to share the…
The special consultation for ALS at the Outpatient Clinic of the Neurological University Hospital Halle (Saale) has been a new partner in the OutpatientPartner network since November 2016. Our network currently consists of 2,300 people with amyotrophic lateral sclerosis (ALS) who are treated at the university hospitals in Berlin, Bochum, Dresden, Hanover, Magdeburg, Jena, Rostock…
A first scientific evaluation of aggregated care data from the Outpatient Partner Network was published this month in “Der Nervenarzt” – the official publication of the German Society of Neurology (DGN). The publication analyzes data on the provision of assistive devices for patients with amyotrophic lateral sclerosis (ALS) in the period from June 2011 to…
During this year’s annual conference of the German Society of Neurology (DGN) in Munich, the DGN poster prize in the motor neuron and muscle diseases category was awarded to a consortium of university ALS outpatient clinics and AmbulanzPartner. The award was given for the scientific contribution ‘Provision of aidsin ALS – analysis from 3 years…
Since June 2014, the AmbulanzPartner Academy has been offering the course“Interdisciplinary spasticity treatment in a network“. The one-day course is aimed at those involved in spasticity treatment, in particular doctors, physiotherapists and occupational therapists as well as neuroorthetics providers. The course develops a concept for interdisciplinary and networked spasticity treatment with botulinum neurotoxin, physiotherapy and…
At the Neurowoche 2014 together with the 87th Congress of the German Society of Neurology (DGN) on September 16, 2014 in Munich, the results of three years of Internet-based care management of assistive devices in amyotrophic lateral sclerosis (ALS) with AmbulanzPartner will be presented in the scientific program.Background: ALS is a prototypical disease for the…

AmbulanzPartner and Charité – Universitätsmedizin Berlin analyzed 1,254 patients with amyotrophic lateral sclerosis (ALS) to determine the rejection rates by health insurance companies and the regional differences in care. Between March 2011 and March 2014, 7,394 medical aids were prescribed by a specialist neurologist and recorded on the AmbulanzPartner.de internet portal. The rejection rate by…
The trade journal “Medizin-Technische Dialog (MTDialog)” features an interview with Thomas Meyer, a founder of AmbulanzPartner (with 13 questions and answers) in its 4-2013 issue (39th year). The topic is“Networks, ambulance partners and care“.